Quite a few insiders invested in NeuBase Therapeutics, Inc. (NASDAQ:NBSE) last year which is positive news for shareholders
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in NeuBase Therapeutics, Inc.’s (NASDAQ:NBSE) case, it’s fantastic news for shareholders.
While we would never suggest that investors…
